Notification of Transactions of
Directors and Persons Discharging Managerial Responsibility
Vesting of conditional share awards granted to senior executives who have since been appointed a Person Discharging Managerial Responsibility (PDMR)
This notification sets out information relating to the vesting of conditional share awards granted in 2009 under the GlaxoSmithKline 2009 Performance Share Plan (the Performance Share Plan).
The conditional awards granted in 2009 to senior executives who have since been appointed PDMRs, were dependent on EPS performance (50% of the award) and operational performance targets (remaining 50% of award) over the period 1 January 2009 to 31 December 2011.
The table below shows the proportion of these Performance Share Plan conditional awards that vested and lapsed on 17 February 2012.
|
Awards vesting under EPS measure - 0% of EPS portion of award |
Awards lapsed under EPS measure - all of EPS portion of award |
Awards vested under operational measure |
Awards lapsed under operational measure |
Ordinary Shares |
Ordinary Shares |
Ordinary Shares |
Ordinary Shares |
|
Mr P Thomson |
0 |
1,744 |
610 |
1,133 |
Dr P Vallance |
0 |
21,035 |
21,035 |
0 |
Mrs V Whyte |
0 |
1,744 |
610 |
1,133 |
The Company and PDMRs were advised of these transactions on 20 February 2012.
The closing middle market price of an Ordinary share of GlaxoSmithKline plc on 17 February 2012 was £14.14.
This notification is made in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
20 February 2012